The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, H.
Right arrow Articles by Dong, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, H.
Right arrow Articles by Dong, F.
The Journal of Immunology, 2006, 176: 2407-2413.
Copyright © 2006 by The American Association of Immunologists

Involvement of Protein Kinase C{epsilon} in the Negative Regulation of Akt Activation Stimulated by Granulocyte Colony-Stimulating Factor1

Hong Liu2,*,{dagger}, Yaling Qiu*, Lei Xiao{ddagger} and Fan Dong3,*

* Department of Biological Sciences, University of Toledo, Toledo, OH 43606; {dagger} Department of Hematology, Hospital of Nantong University, Nantong, Jiangsu, China; and {ddagger} University Florida Shands Cancer Center Department of Anatomy and Cell Biology, University of Florida, Gainesville, FL 32610

Stimulation of cells with G-CSF activates multiple signaling cascades, including the serine/threonine kinase Akt pathway. We show in this study that G-CSF-induced activation of Akt in myeloid 32D was specifically inhibited by treatment with PMA, a protein kinase C (PKC) activator. PMA treatment also rapidly attenuated sustained Akt activation mediated by a carboxy truncated G-CSF receptor, expressed in patients with acute myeloid leukemia evolving from severe congenital neutropenia. The inhibitory effect of PMA was abolished by pretreatment of cells with specific PKC inhibitor GF109203X, suggesting that the PKC pathway negatively regulates Akt activation. Ro31-8820, a PKC{epsilon} inhibitor, also abrogated PMA-mediated inhibition of Akt activation, whereas rottlerin and Go6976, inhibitors of PKC{delta} and PKC{alpha}betaI, respectively, exhibited no significant effects. Furthermore, overexpression of the wild-type and a constitutively active, but not a kinase-dead, forms of PKC{epsilon} markedly attenuated Akt activation, and inhibited the proliferation and survival of cells in response to G-CSF. The expression of PKC{epsilon} was down-regulated with G-CSF-induced terminal granulocytic differentiation. Together, these results implicate PKC{epsilon} as a negative regulator of Akt activation stimulated by G-CSF and indicate that PKC{epsilon} plays a negative role in cell proliferation and survival in response to G-CSF.




This article has been cited by other articles:


Home page
Int ImmunolHome page
A. Oda, T. Ono, M. Yamamoto, R. Goitsuka, and D. Kitamura
PKC{eta} directs induction of IRF-4 expression and Ig {kappa} gene rearrangement in pre-BCR signaling pathway
Int. Immunol., September 9, 2008; (2008) dxn101v1.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Buitenhuis, L. P. Verhagen, H. W. M. van Deutekom, A. Castor, S. Verploegen, L. Koenderman, S.-E. W. Jacobsen, and P. J. Coffer
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
Blood, January 1, 2008; 111(1): 112 - 121.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.